Orabloc side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Orabloc. Common side effects include drug effect prolonged among females and drug ineffective among males.

The phase IV clinical study is created by eHealthMe based on 69 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 16, 2022

69 people who take Orabloc and have side effects are studied.


What is Orabloc?

Orabloc has active ingredients of articaine hydrochloride; epinephrine bitartrate. eHealthMe is studying from 69 Orabloc users for its effectiveness, alternative drugs and more.

Number of Orabloc reports submitted per year:

Orabloc side effects.

Orabloc side effects by time on the drug*:

< 1 month:

  1. Drug ineffective
  2. Drug effect prolonged
  3. Laryngeal oedema (swelling of larynx)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Suicidal ideation
  6. Swelling
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Administration site pain
  9. Trismus (reduced opening of the jaws)
  10. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Ageusia (loss of taste functions of the tongue)
  3. Blood pressure immeasurable
  4. Blood pressure increased
  5. Drug effect prolonged
  6. Drug ineffective
  7. Headache (pain in head)
  8. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  9. Lip swelling
  10. Metal poisoning

Orabloc side effects by gender *:

female:

  1. Drug effect prolonged
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  4. Anxiety
  5. Blood pressure immeasurable
  6. Blood pressure increased
  7. Cheilitis (infection of lips)
  8. Injection site pain
  9. Metal poisoning
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

  1. Drug ineffective
  2. Drug effect prolonged
  3. Trismus (reduced opening of the jaws)
  4. Ageusia (loss of taste functions of the tongue)
  5. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  6. Headache (pain in head)
  7. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  8. Laryngeal oedema (swelling of larynx)
  9. Lip swelling

Orabloc side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug ineffective
  2. Administration site pain
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

20-29:

  1. Drug ineffective
  2. Administration site pain

30-39:

  1. Drug ineffective
  2. Blood pressure immeasurable
  3. Cheilitis (infection of lips)
  4. Metal poisoning

40-49:

  1. Drug effect prolonged
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Blood pressure increased
  4. Drug ineffective
  5. Laryngeal oedema (swelling of larynx)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

  1. Drug ineffective
  2. Injection site pain

60+:

  1. Drug effect prolonged
  2. Drug ineffective
  3. Anxiety
  4. Headache (pain in head)
  5. Systolic hypertension (an elevated systolic blood pressure)

* Approximation only. Some reports may have incomplete information.

Do you take Orabloc?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on articaine hydrochloride; epinephrine bitartrate (the active ingredients of Orabloc) and Orabloc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Orabloc:

All Orabloc side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: